1. Home
  2. WTBA vs ADCT Comparison

WTBA vs ADCT Comparison

Compare WTBA & ADCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo West Bancorporation

WTBA

West Bancorporation

HOLD

Current Price

$22.59

Market Cap

375.9M

Sector

Finance

ML Signal

HOLD

Logo ADC Therapeutics SA

ADCT

ADC Therapeutics SA

HOLD

Current Price

$4.02

Market Cap

484.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
WTBA
ADCT
Founded
1893
2011
Country
United States
Switzerland
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
375.9M
484.4M
IPO Year
2002
2019

Fundamental Metrics

Financial Performance
Metric
WTBA
ADCT
Price
$22.59
$4.02
Analyst Decision
Hold
Strong Buy
Analyst Count
1
4
Target Price
$24.00
$7.50
AVG Volume (30 Days)
31.3K
838.7K
Earning Date
04-23-2026
03-10-2026
Dividend Yield
4.34%
N/A
EPS Growth
35.21
30.86
EPS
1.92
N/A
Revenue
N/A
$81,357,000.00
Revenue This Year
$23.69
N/A
Revenue Next Year
$9.18
$68.29
P/E Ratio
$11.86
N/A
Revenue Growth
N/A
14.85
52 Week Low
$17.33
$1.05
52 Week High
$26.60
$4.98

Technical Indicators

Market Signals
Indicator
WTBA
ADCT
Relative Strength Index (RSI) 39.59 46.47
Support Level $22.23 $3.79
Resistance Level $24.16 $4.77
Average True Range (ATR) 0.77 0.28
MACD -0.18 -0.05
Stochastic Oscillator 23.31 9.91

Price Performance

Historical Comparison
WTBA
ADCT

About WTBA West Bancorporation

West Bancorp Inc is a United States-based company that offers a full range of deposit services, including checking, savings and money market accounts and time certificates of deposit. West Bank also offers online banking, mobile banking, and treasury management services, which help to meet the banking needs of its customers. Treasury management services offered to business customers include cash management, client-generated automated clearing house transactions, remote deposit, and fraud protection services. Also offered are merchant credit card processing and corporate credit cards. The bank operates only in the United States of America region.

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's FDA-approved and marketed product, ZYNLONTA (loncastuximab tesirine), is a CD19-directed antibody and alkylating agent conjugate indicated for the treatment of adult patients with relapsed or refractory large B-cell lymphoma after two or more lines of systemic therapy. In addition, it also has various other product candidates in its pipeline, such as ADCT-602, Claudin-6, PSMA, NaPi2b, and ASCT2. Geographically, the company generates maximum revenue from the United States, followed by Europe, the Middle East and Africa (EMEA).

Share on Social Networks: